| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |